The study, which is a special feature on the iPAD version of the Journal of the American College of Cardiology, provides compelling evidence that the answer to treating cardiovascular disease and other obesity-related disorders, such as type 2 diabetes and cancer, might be found in the adipose tissue itself.
While obesity is a leading preventable cause of death in the United States, its prevalence continues to increase rapidly among individuals of all ethnicities and age groups. According to the National Institutes of Health, more than 33 percent of men and women above the age of 20 in the United States are obese and 68% are overweight.
Led by Noyan Gokce, MD, a cardiologist at BMC and an associate professor of medicine at BUSM, the researchers examined adipose tissue samples from both lean and obese individuals. The study subjects, all of whom were receiving care at BMC, included 109 obese men and women and 17 lean men and women between the ages of 21 and 55.
After obtaining the samples, the tissue was biopsied and evaluated for the amount of inflammation present in the tissue. They then performed a vascular ultrasound on the forearm artery to examine blood vessel function. After compiling the information, the researchers saw that lean individuals exhibited no adipose inflammation and normal vascular function whereas the obese individuals exhibited significant inflammation and poor vascular function.
While these study findings are consistent with other epidemiological obesity studies, this research team identified that 30 percent of the obese subjects demonstrated reduced fat inflammation, less insulin resistance, and their vascular function was similar to a lean person despite severe obesity. The study suggests that humans prone to inflammation in association with weight gain may be more susceptible to cardiovascular and metabolic disease risks.
"While it is widely believed that obesity and inflammation are linked to cardiovascular disease, this study shows not all obese individuals exhibit inflammation that can lead to cardiovascular disease, type 2 diabetes and cancer," said Gokce, the study's senior author. "Once we identify what harmful products adipose tissue is producing that is linked to causing systemic inflammation, we can explore treatments against it that could potentially combat the development of several debilitating obesity-related disorders."
This study was funded by The National Institutes of Health. Other researchers involved with the study include: Melissa G. Farb, PhD, Sherman Bigornia, MA, Melanie Mott, MS, RD, Kahraman Tanriverdi, PhD, Kristine M. Morin, MPH, Jane E. Freedman, MD, Lija Joseph, MD, Donald T. Hess, MD, Caroline M. Apovian, MD, and Joseph A. Vita, MD.
About Boston Medical Center
Boston Medical Center is a private, not-for-profit, 508-bed, academic medical center that is the primary teaching affiliate of Boston University School of Medicine. Committed to providing high-quality health care to all, the hospital offers a full spectrum of pediatric and adult care services including primary and family medicine and advanced specialty care with an emphasis on community-based care. Boston Medical Center offers specialized care for complex health problems and is a leading research institution. Boston Medical Center and Boston University School of Medicine are partners in the Boston HealthNet—15 community health centers focused on providing exceptional health care to residents of Boston. For more information, please visit www.bmc.org
About Boston University School of Medicine
Originally established in 1848 as the New England Female Medical College, and incorporated into Boston University in 1873, Boston University School of Medicine today is a leading academic medical center with an enrollment of more than 700 medical students and more than 800 masters and PhD students. Its 1,246 full and part-time faculty members generated more than $335 million in funding in the 2009-2010 academic year for research in amyloidosis, arthritis, cardiovascular disease, cancer, infectious disease, pulmonary disease and dermatology among others. The School is affiliated with Boston Medical Center, its principal teaching hospital, the Boston and Bedford Veterans Administration Medical Centers and 16 other regional hospitals as well as the Boston HealthNet.
Jenny Eriksen | EurekAlert!
Smart Data Transformation – Surfing the Big Wave
02.12.2016 | Fraunhofer-Institut für Angewandte Informationstechnik FIT
Climate change could outpace EPA Lake Champlain protections
18.11.2016 | University of Vermont
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
08.12.2016 | Life Sciences
08.12.2016 | Physics and Astronomy
08.12.2016 | Materials Sciences